Biological Aging and Venous Thromboembolism: A Review of Telomeres and Beyond
Although venous thromboembolism (VTE) is the third most common cardiovascular disease, and the risk of VTE increases sharply with advancing age, approximately 40% of VTE cases are currently classified as unprovoked, highlighting the importance of risk factor research. While chronological aging is as...
Saved in:
Main Authors: | Rafaela Vostatek, Cihan Ay |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/13/1/15 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of recurrence and bleeding in patients with cancer‐associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study
by: Mette Søgaard, et al.
Published: (2019-03-01) -
Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study
by: Jonatan Ahrén, et al.
Published: (2025-03-01) -
Risk factors for venous thromboembolism after hip arthroscopy: a systematic review and meta-analysis
by: Haoxuan Li, et al.
Published: (2025-02-01) -
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
by: Marte Svalastoga, et al.
Published: (2025-01-01) -
Venous thromboembolism in bullous pemphigoid: current evidence and update on systematic review
by: Atheer G. Almutairi, et al.
Published: (2025-01-01)